Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

16.99
Delayed Data
As of Dec 08
 +0.22 / +1.31%
Today’s Change
15.92
Today|||52-Week Range
44.57
-60.63%
Year-to-Date
No recent news for Myriad Genetics Inc.

Today’s Trading

Previous close16.77
Today’s open16.84
Day’s range16.58 - 17.05
Volume981,887
Average volume (3 months)1,843,186
Market cap$1.2B
Dividend yield--
Data as of 12/08/2016

Growth & Valuation

Earnings growth (last year)+58.33%
Earnings growth (this year)-37.50%
Earnings growth (next 5 years)+3.80%
Revenue growth (last year)+4.25%
P/E ratio13.4
Price/Sales2.98
Price/Book1.57

Competitors

 Today’s
change
Today’s
% change
AAAPAdvanced Accelerator...-0.11-0.36%
VIVOMeridian Bioscience ...+0.20+1.12%
QDELQuidel Corp+0.53+2.39%
--Quidel Corp-0.11-0.54%
Data as of 12/08/2016

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$753.8M
Annual profit (last year)$125.3M
Net profit margin16.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts


Search for Jobs